TFC Financial Management’s Charles River Laboratories CRL Stock Holding History

TFC Financial Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.07K	Hold	7	–	–	﹤0.01%	575
2026 Q2	$1.59K	Buy	7 +6	+600%	+$1.07K	﹤0.01%	598
2026 Q1	$173	Hold	1	–	–	﹤0.01%	804
2025 Q4	$200	Hold	1	–	–	﹤0.01%	775
2025 Q3	$157	Hold	1	–	–	﹤0.01%	835
2025 Q2	$152	Sell	1 -2	-67%	-$267	﹤0.01%	823
2025 Q1	$452	Buy	+3	New	+$503	﹤0.01%	660
2024 Q4	–	Sell	-1	Closed	-$197	–	991
2024 Q3	$197	Buy	+1	New	+$208	﹤0.01%	750
2024 Q2	–	Sell	-1	Closed	-$271	–	996
2024 Q1	$271	Buy	+1	New	+$239	﹤0.01%	696

Other funds holding CRL

Cooke & Bieler Philadelphia, Pennsylvania $6.36B AUM 0.55% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Lawson Kroeker Investment Management Omaha, Nebraska $360M AUM 21.88% 1-Year Est. Return

Midwest Trust Overland Park, Kansas $8.99B AUM 21.14% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

TFC Financial Management's CRL Position: Q3 2026 in Review

TFC Financial Management held its Charles River Laboratories (CRL) position steady in Q3 2026 at 7 shares worth $2.07K. The position accounts for ﹤0.01% of the portfolio, ranked #575.

TFC Financial Management first reported a position in CRL in Q1 2024 and has held it in 9 quarters since. 172 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

TFC Financial Management held 7 shares of Charles River Laboratories worth $2.07K as of Q3 2026.
TFC Financial Management left its Charles River Laboratories share count unchanged in Q3 2026.
Charles River Laboratories made up ﹤0.01% of TFC Financial Management's portfolio in Q3 2026, its #575 holding.
TFC Financial Management first reported a position in Charles River Laboratories in Q1 2024 and has held it in 9 quarters since.
172 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on TFC Financial Management's 13F filing for Q3 2026, filed 26 Oct 2026.